ArriVent BioPharma, Inc.
AVBP
$20.11
$0.231.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -21.09% | -44.52% | 45.53% | 70.03% | 63.36% |
| Total Receivables | -32.67% | -42.29% | -34.30% | -54.09% | 190.70% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -35.76% | -15.75% | 10.60% | 298.95% | 186.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 67.41% | 2.84% | -14.69% | -35.47% | -48.13% |
| Total Current Assets | -18.92% | -43.27% | 41.89% | 62.46% | 55.28% |
|
|
|||||
| Total Current Assets | -18.92% | -43.27% | 41.89% | 62.46% | 55.28% |
| Net Property, Plant & Equipment | -61.19% | -52.00% | -47.08% | 325.00% | 188.16% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 283.20% | 62.96% | -95.56% | -93.58% | 52.44% |
| Total Assets | -12.74% | -34.27% | 68.57% | 60.84% | 55.33% |
|
|
|||||
| Total Accounts Payable | 6.51% | 6.49% | -16.55% | -3.57% | -40.97% |
| Total Accrued Expenses | 90.29% | 47.44% | 91.74% | 97.77% | 29.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -35.53% | -6.12% | 15.71% | 256.82% | 100.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 62.31% | 29.83% | 48.61% | 50.12% | -5.58% |
|
|
|||||
| Total Current Liabilities | 62.31% | 29.83% | 48.61% | 50.12% | -5.58% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -92.09% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 61.00% | 28.06% | 46.50% | 50.67% | -4.82% |
|
|
|||||
| Common Stock & APIC | 18.27% | 2.49% | 10,566.34% | 11,820.87% | 12,922.02% |
| Retained Earnings | -69.49% | -72.72% | -50.99% | -59.31% | -61.26% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -15.77% | -36.25% | 268.19% | 309.26% | 350.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.77% | -36.25% | 268.19% | 309.26% | 350.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.77% | -36.25% | 70.30% | 61.44% | 59.47% |
|
|
|||||